Market Overview

Alnylam, Tekmira Resolve All Litigation; Alnylam to Make $65M One-Time Payment

Related ALNY
Deutsche Bank Loves These Small-Cap Biotech Stocks
Mid-Afternoon Market Update: Alnylam Pharmaceuticals Drops Following Equity Offering; Insperity Shares Spike Higher
Action in Ebola-Related Stocks (Fox Business)
Related TKMR
Falcon Edge Takes Passive Stake In Tekmira Pharmaceuticals
Morning Market Gainers
Making Money With Charles Payne: 10/24/14 (Fox Business)

Alnylam (NASDAQ: ALNY) and Tekmira Pharma (NASDAQ: TKMR) announced a settlement agreement that resolves all litigation between the companies, and has signed a new licensing agreement that restructures the relationship and provides clarity on all intellectual property and licensing issues between the companies. As a result of the restructuring and new agreements, Tekmira will receive $65 million within 10 days and is eligible to receive $10 million in near-term milestone payments expected to be received in 2013.

Posted-In: News Legal


Related Articles (ALNY + TKMR)

Around the Web, We're Loving...

Get Benzinga's Newsletters